Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy
A study of the new drug Lonsurf in gastric cancer found that the treatment was tolerable and improved overall survival in patients... Read More
Better Short-Term Results With LADG in Stomach Cancer
A study found that patients who undergo minimally invasive laparoscopic gastrectomy are better able to tolerate chemotherapy for gastric cancer than are... Read More
Survival Benefit of Palliative Gastrectomy Followed by Chemotherapy for Stage IV Gastric Signet Ring Cell Carcinoma – copy
A study found a high rate of H. Pylori in patients undergoing sleeve gastrectomy for weight loss. That suggests there’s value in... Read More
Survival Benefit of Palliative Gastrectomy Followed by Chemotherapy for Stage IV Gastric Signet Ring Cell Carcinoma
Gastrectomy followed by chemotherapy can be more effective than chemo alone in gastric cancer patients with signet ring cell carcinoma, according to... Read More
“American chef without a stomach inspires Catharina Hospital”
In April, Board Member and “Chef without a Stomach,” Hans Rueffert, traveled overseas to meet with chefs, dieticians and surgeons from the... Read More
Laparoscopic Gastrectomy an Option in Gastric Cancer
A new study shows that laparoscopic surgery in gastric cancer patients produces similar disease-free survival as more invasive open procedures.
Taiho Oncology and Servier Present Data on LONSURF (trifluridine/tipiracil) at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)
A new study evaluating LONSURF in patients with previously treated metastatic gastric cancer is consistent with the overall study results published in... Read More
Timing of postoperative chemotherapy in patients undergoing perioperative chemotherapy and gastrectomy for gastric cancer
A study examines the timing of postoperative chemo on survival of gastric cancer patients who underwent perioperative chemotherapy and gastrectomy.